Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05654220 · ClinicalTrials.gov registry record · NA
Linking Emergency Department Patients to Assistance Programs Study
A NA study of Social Determinants of Health, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT05654220: Completed NA study of Social Determinants of Health, sponsored by University of Pennsylvania.
NCT05654220 is a NA study of Social Determinants of Health that has completed, run by University of Pennsylvania. The registered enrollment target is 161 participants, below the 5,027-participant average among 11 other Social Determinants of Health trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05654220, a NA study of Social Determinants of Health, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this randomized controlled trial is to test the effect of screening patients in Penn Medicine Emergency Departments for eligibility of public benefits programs and using text messages post-discharge to connect patients to benefits enrollment specialists at Benefits Data Trust (BDT). Eligible patients will be randomly selected to receive text messages for two weeks after Emergency Department discharge with the phone number to speak with a benefits enrollment specialist at BDT. The number of calls to the BDT phone line and the number of submitted applications to public benefits programs will be compared between patients receiving a summary flyer with the phone number for BDT and the text message intervention to connect with BDT in comparison to an active control group who receives only a summary flyer with the phone number for BDT.
Primary Outcome
Participant connection to BDT measured by phone calls completed by confirmed participants to BDT.
Conditions Studied
Interventions
- BEHAVIORAL Text Messaging Intervention
Study Locations (1)
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT05654220 record still lists
NCT05654220 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 5,027-participant average among 11 other Social Determinants of Health trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Social Determinants of Health appearing as the primary indexed condition, and to 1 intervention - of which Text Messaging Intervention is the first listed.
NCT05654220 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05654220 about?
NCT05654220 is a clinical study titled "Linking Emergency Department Patients to Assistance Programs Study". The objective of this randomized controlled trial is to test the effect of screening patients in Penn Medicine Emergency Departments for eligibility of public benefits programs and using text messages post-discharge to connect patients to benefits enrollment specialists at Benefits Data Trust (BDT)....
What is the current status of trial NCT05654220?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2023-07-19. Estimated completion is 2024-06-30.
What conditions does trial NCT05654220 study?
This clinical trial studies the following conditions: Social Determinants of Health.
What interventions are being tested in trial NCT05654220?
The interventions under investigation include: Text Messaging Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05654220?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05654220 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Determinants of Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05654220's enrollment target sits among peer trials
161 9th of 11 higher than 3 of 11 other Social Determinants of Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Social Determinants of Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
-
Predictive Modeling for Social Needs in Emergency Department Settings
RECRUITING · NA
-
SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes
RECRUITING · NA
-
Health Equity and Rural Education (HERE!) Clinical Trial
RECRUITING · NA
-
Social Risk Factors and Discrimination in Cancer Survivorship
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI